Jane Street Group, LLC Adma Biologics, Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

A detailed history of Jane Street Group, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 434,591 shares of ADMA stock, worth $8.55 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
434,591
Previous 95,630 354.45%
Holding current value
$8.55 Million
Previous $631,000 669.89%
% of portfolio
0.01%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.98 - $11.18 $2.03 Million - $3.79 Million
338,961 Added 354.45%
434,591 $4.86 Million
Q1 2024

May 15, 2024
SELL
$4.4 - $6.74 $259,265 - $397,147
-58,924 Reduced 38.13%
95,630 $631,000
Q4 2023

Feb 14, 2024
BUY
$3.08 - $4.52 $212,883 - $312,413
69,118 Added 80.9%
154,554 $698,000
Q3 2023

Nov 14, 2023
SELL
$3.47 - $4.61 $1.13 Million - $1.5 Million
-326,182 Reduced 79.24%
85,436 $305,000
Q2 2023

Aug 14, 2023
BUY
$3.12 - $4.22 $1.24 Million - $1.68 Million
396,943 Added 2704.89%
411,618 $1.52 Million
Q1 2023

May 15, 2023
SELL
$3.01 - $3.87 $485,166 - $623,785
-161,185 Reduced 91.66%
14,675 $48,000
Q4 2022

Feb 14, 2023
BUY
$2.47 - $3.88 $316,214 - $496,725
128,022 Added 267.62%
175,860 $682,000
Q3 2022

Nov 14, 2022
BUY
$2.03 - $2.86 $67,406 - $94,966
33,205 Added 226.92%
47,838 $116,000
Q2 2022

Aug 16, 2022
SELL
$1.43 - $2.2 $871,918 - $1.34 Million
-609,733 Reduced 97.66%
14,633 $29,000
Q1 2022

May 17, 2022
BUY
$1.28 - $1.83 $702,181 - $1 Million
548,579 Added 723.84%
624,366 $1.14 Million
Q4 2021

Feb 15, 2022
BUY
$1.09 - $1.66 $46,086 - $70,186
42,281 Added 126.19%
75,787 $107,000
Q3 2021

Nov 16, 2021
SELL
$1.13 - $1.65 $24,827 - $36,252
-21,971 Reduced 39.6%
33,506 $38,000
Q2 2021

Aug 16, 2021
BUY
$1.51 - $2.07 $49,626 - $68,030
32,865 Added 145.34%
55,477 $89,000
Q1 2021

May 18, 2021
BUY
$1.67 - $2.95 $37,762 - $66,705
22,612 New
22,612 $40,000
Q4 2020

Feb 17, 2021
SELL
$1.8 - $2.56 $36,100 - $51,343
-20,056 Closed
0 $0
Q3 2020

Nov 17, 2020
SELL
$2.04 - $3.74 $31,165 - $57,135
-15,277 Reduced 43.24%
20,056 $48,000
Q1 2020

May 15, 2020
SELL
$1.5 - $4.59 $192,237 - $588,245
-128,158 Reduced 78.39%
35,333 $102,000
Q4 2019

Feb 14, 2020
BUY
$3.89 - $5.15 $113,572 - $150,359
29,196 Added 21.74%
163,491 $654,000
Q3 2019

Nov 14, 2019
BUY
$3.19 - $5.39 $242,187 - $409,214
75,921 Added 130.06%
134,295 $598,000
Q2 2019

Aug 15, 2019
BUY
$3.52 - $5.24 $41,222 - $61,365
11,711 Added 25.1%
58,374 $226,000
Q1 2019

May 16, 2019
BUY
$2.61 - $4.35 $121,790 - $202,984
46,663 New
46,663 $177,000

Others Institutions Holding ADMA

# of Institutions
290
Shares Held
179M
Call Options Held
535K
Put Options Held
21.2K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.86B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email